June 27th marks PTSD Awareness Day, a day dedicated to shedding light on Post-Traumatic Stress Disorder (PTSD) and its profound impact on millions of lives. This awareness day aims to increase understanding, reduce stigma, and promote support for those affected by this mental health condition.
And in recent years, advancements in treatment options have offered new hope for those struggling with PTSD. One such promising treatment is SPRAVATO® (esketamine), a fast-acting nasal spray approved for major depression and showing potential for treating PTSD. It provides a new avenue for relief when traditional treatments fall short.
As we observe PTSD Awareness Day, it's essential to explore innovative treatments like SPRAVATO® that can make a significant difference in the lives of those living with PTSD.
PTSD is a mental health condition that develops after experiencing or witnessing a traumatic event. These events can range from military combat and natural disasters to serious accidents and personal assaults.
Individuals with PTSD often experience intense, disturbing thoughts and feelings related to their trauma long after the event has ended.
Unfortunately, PTSD is more common than many realize. According to the National Center for PTSD, about 60% of men and 50% of women living in the United States will experience trauma at some point in their lives, and 1 out of 11 people will develop PTSD in their lifetime. For example, approximately 13 million people had PTSD in 2020.
Additionally, around one-third of individuals who experience severe trauma will develop PTSD. Among those diagnosed with PTSD, research finds 22.3% of them will fall into the category of severe symptoms.
However, the impact of PTSD extends beyond the individual. It can affect entire families, workplaces, and communities. Studies show that people with PTSD often struggle with maintaining relationships, holding jobs, and enjoying daily activities due to the condition's pervasive symptoms like avoidance, emotional numbing, and hyperarousal.
The prevalence of PTSD in America translates to millions of individuals dealing with the disorder's debilitating effects in a multitude of ways.
SPRAVATO® (esketamine) is a groundbreaking nasal spray, administered under the supervision of a healthcare provider, designed to treat severe forms of depression and PTSD. Unlike traditional antidepressants that typically take weeks to show effects, SPRAVATO® works quickly, often providing relief within hours or days.
SPRAVATO® was developed by Johnson & Johnson. The FDA approved it in 2019 for use in treatment-resistant depression (TRD). This approval came after rigorous clinical trials demonstrated its effectiveness in patients who had not responded to other forms of treatment.
Recognizing its potential, researchers continued to explore its benefits for other conditions, leading to its consideration for PTSD treatment.
Most traditional antidepressants work by increasing levels of serotonin and other neurotransmitters over time. In contrast, SPRAVATO® targets the brain's glutamate system, specifically the N-methyl-D-aspartate (NMDA) receptors. By modulating these receptors, SPRAVATO® helps to rapidly restore balance in the brain's mood-regulating systems (which are significantly impacted in those living with PTSD).
Another key difference is the method of nasal administration, which allows for direct and rapid absorption. This delivery method, combined with its fast-acting nature, makes SPRAVATO® a valuable option for those in urgent need of relief from severe depression and PTSD symptoms.
SPRAVATO® is a valuable option for those who have exhausted other avenues, as it delivers an array of positive benefits:
While talk therapy and mental health medication remain a cornerstone of PTSD treatment, the addition of SPRAVATO® provides a powerful tool for those who have not found relief through conventional methods. It speaks to the heart of what many with PTSD desperately need: immediate relief and a path forward.
When considering SPRAVATO® for PTSD treatment, it is essential to be aware of potential side effects and the importance of proper monitoring during treatment.
SPRAVATO® can cause several side effects, most of which are mild to moderate and occur shortly after administration. Side effects may include, but are not limited to:
These effects are usually temporary, but it is crucial to inform your healthcare provider if they persist or worsen, as they can help you manage any new symptoms that arise.
Because of its potent effects, SPRAVATO® is administered in a certified healthcare setting under the supervision of a trained healthcare provider. During each session, your provider will monitor your vital signs and observe you for any adverse reactions. This controlled environment ensures immediate intervention if necessary and helps optimize the treatment's safety and effectiveness.
It is also important to consider potential interactions with other medications and lifestyle factors. Inform your healthcare provider of all medicines you are currently taking, as some may interact with SPRAVATO® and alter its effects. Your provider will evaluate any potential interactions and adjust your treatment plan accordingly.
Additionally, maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding substance use, can enhance the benefits of SPRAVATO® treatment.
PTSD Awareness Day serves as a reminder of the profound impact PTSD has on individuals and society. This awareness-raising is crucial for several reasons:
Additionally, treatments like SPRAVATO® play a crucial role in the conversation about PTSD because it provides hope for those who have not found success with traditional therapies. It symbolizes the progress being made in the field of mental health and the potential for recovery and improved quality of life.
Hearing real-life experiences from those who have undergone SPRAVATO® treatment can provide invaluable insight for those considering this innovative PTSD treatment option or wanting to learn more about its positive impact.
Ultimately, PTSD Awareness Day is about fostering a community that understands and supports those with PTSD, advocating for continued advancements in treatment, and spreading hope that healing is possible. It's a day to remember that with the proper support and resources, individuals with PTSD can lead fulfilling lives.
In summary, SPRAVATO® offers a groundbreaking approach to treating PTSD, providing rapid symptom relief and hope for those who have struggled with traditional treatments. Its unique mechanism of action and fast-acting abilities make it a valuable option for those seeking effective and sustained relief from the debilitating effects of PTSD.
As we observe PTSD Awareness Day, let us spread awareness and support. A bit of understanding and empathy can make a significant difference in the lives of those living with PTSD. Together, we can build a community that supports healing and recovery, offering hope and new possibilities for a brighter future.
If you or someone you know struggles with symptoms of PTSD, SPRAVATO® may be right for you. At Psychiatry Treatment Centers, we have clinics across southern California (Hollywood and Beverly Grove) and southeast Georgia (Hinesville, Jesup, and Richmond Hill) that can offer the support you've been looking for.
Reach out to us today to learn how you can turn a page in the next chapter of your mental health journey. Our expert team is ready to provide you with compassionate, personalized care every step of the way.
Bahr, Rebecca et al. “Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant.” P & T : a peer-reviewed journal for formulary management vol. 44,6 (2019): 340-375.
J. Gayle Beck, DeMond M. Grant, Joshua D. Clapp, Sarah A. Palyo, Understanding the interpersonal impact of trauma: Contributions of PTSD and depression, Journal of Anxiety Disorders, Volume 23, Issue 4, 2009, Pages 443-450, ISSN 0887-6185, https://doi.org/10.1016/j.janxdis.2008.09.001.
Kessler, Ronald C et al. “Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.” Archives of general psychiatry vol. 62,6 (2005): 617-27. doi:10.1001/archpsyc.62.6.617
When you suffer from depression or a neurological disorder, you are not alone. Get help with depression today!
PTC has locations in Los Angeles CA and Northeast Georgia!
At PTC, we are dedicated to promoting both your personal mental health and the well-being of our community. If you live in or near Hinesville or Jesup Georgia, Beverly Grove, Hollywood, or Los Angeles California and surrounding areas, we can help you regain your mental well-being. Our TMS treatments are typically covered by most insurance plans, are FDA-approved, non-invasive, and have no drug-related side effects.
Get the psychiatric support you need – it’s time.
NAVIGATION
CONTACT
(833) 4-PTCMED
Mon - Fri 8am - 5pm
Sat - Sun Closed
Hours may vary by location
Copyright © PTC Med | Privacy Policy | Terms & Conditions